| Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1 TH Lee, S Seng, M Sekine, C Hinton, Y Fu, HK Avraham, S Avraham PLoS medicine 4 (6), e186, 2007 | 346 | 2007 |
| Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population M Sekine, H Nagata, S Tsuji, Y Hirai, S Fujimoto, M Hatae, I Kobayashi, ... Clinical Cancer Research 7 (10), 3144-3150, 2001 | 113 | 2001 |
| Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer Y Aoki, M Watanabe, T Amikura, H Obata, M Sekine, T Yahata, K Fujita, ... Gynecologic oncology 94 (2), 333-339, 2004 | 85 | 2004 |
| Japan’s failure to vaccinate girls against human papillomavirus Y Ueda, T Enomoto, M Sekine, T Egawa-Takata, A Morimoto, T Kimura American Journal of Obstetrics & Gynecology 212 (3), 405-406, 2015 | 74 | 2015 |
| Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination A Morimoto, Y Ueda, T Egawa-Takata, A Yagi, Y Terai, M Ohmichi, ... International journal of clinical oncology 20, 549-555, 2015 | 72 | 2015 |
| Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan M Arai, S Yokoyama, C Watanabe, R Yoshida, M Kita, M Okawa, ... Journal of human genetics 63 (4), 447-457, 2018 | 69 | 2018 |
| Bivalent human papillomavirus vaccine effectiveness in a japanese population: High vaccine-type–specific effectiveness and evidence of cross-protection R Kudo, M Yamaguchi, M Sekine, S Adachi, Y Ueda, E Miyagi, M Hara, ... The Journal of infectious diseases 219 (3), 382-390, 2019 | 68 | 2019 |
| Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma C Banzai, K Nishino, J Quan, K Yoshihara, M Sekine, T Yahata, K Tanaka, ... International journal of clinical oncology 19, 127-132, 2014 | 66 | 2014 |
| Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies K Fujiwara, K Shimano, H Tanaka, M Sekine, K Kashiwase, M Uchikawa, ... Vox sanguinis 96 (3), 244-251, 2009 | 54 | 2009 |
| HPV vaccination in Japan: what is happening in Japan? S Ikeda, Y Ueda, A Yagi, S Matsuzaki, E Kobayashi, T Kimura, E Miyagi, ... Expert review of vaccines 18 (4), 323-325, 2019 | 51 | 2019 |
| Germline copy number variations in BRCA1‐associated ovarian cancer patients K Yoshihara, A Tajima, S Adachi, J Quan, M Sekine, H Kase, T Yahata, ... Genes, Chromosomes and Cancer 50 (3), 167-177, 2011 | 49 | 2011 |
| Cigarette smoking and glutathione S‐transferase M1 polymorphism associated with risk for uterine cervical cancer K Nishino, M Sekine, S Kodama, N Sudo, Y Aoki, N Seki, K Tanaka Journal of Obstetrics and Gynaecology Research 34 (6), 994-1001, 2008 | 47 | 2008 |
| Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy T Yahata, M Numata, K Kashima, M Sekine, K Fujita, T Yamamoto, ... Gynecologic oncology 109 (1), 49-52, 2008 | 46 | 2008 |
| Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma K Nishino, Y Aoki, T Amikura, H Obata, M Sekine, T Yahata, K Fujita, ... Gynecologic oncology 97 (3), 893-897, 2005 | 46 | 2005 |
| Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer H Obata, T Yahata, J Quan, M Sekine, K Tanaka Anticancer research 26 (3B), 2227-2232, 2006 | 45 | 2006 |
| Realistic fear of cervical cancer risk in Japan depending on birth year A Yagi, Y Ueda, T Egawa-Takata, Y Tanaka, R Nakae, A Morimoto, ... Human Vaccines & Immunotherapeutics 13 (7), 1700-1704, 2017 | 42 | 2017 |
| Sox2‐dependent inhibition of p21 is associated with poor prognosis of endometrial cancer K Yamawaki, T Ishiguro, Y Mori, K Yoshihara, K Suda, R Tamura, ... Cancer science 108 (4), 632-640, 2017 | 41 | 2017 |
| Increased incidence of brain metastases in BRCA1‐related ovarian cancers M Sekine, K Yoshihara, D Komata, K Haino, K Nishino, K Tanaka Journal of Obstetrics and Gynaecology Research 39 (1), 292-296, 2013 | 41 | 2013 |
| Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year Y Ueda, A Yagi, T Nakayama, K Hirai, S Ikeda, M Sekine, E Miyagi, ... Scientific reports 8 (1), 5612, 2018 | 40 | 2018 |
| Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22–p25 M Sekine, H Nagata, S Tsuji, Y Hirai, S Fujimoto, M Hatae, I Kobayashi, ... Human molecular genetics 10 (13), 1421-1429, 2001 | 40 | 2001 |
